HMGCR Inhibitor Restores Mitochondrial Dynamics by Regulating Signaling Cascades in a Rodent Alzheimer's Disease Model.
Alzheimer’s disease
Atorvastatin
Aβ1–42
Neurodegeneration
Neuroprotection
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
13 Sep 2024
13 Sep 2024
Historique:
received:
16
12
2023
accepted:
30
08
2024
medline:
14
9
2024
pubmed:
14
9
2024
entrez:
13
9
2024
Statut:
aheadofprint
Résumé
Atorvastatin an HMGCR inhibitor may play a role in enhancing spatial and long-term memory and combating anxious behavior deficits induced by Aβ
Identifiants
pubmed: 39271623
doi: 10.1007/s12035-024-04465-1
pii: 10.1007/s12035-024-04465-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Indian Council of Medical Research
ID : File No. 45/14/2020/PHA/BMS
Organisme : Indian Council of Medical Research
ID : File No. 45/14/2020/PHA/BMS
Organisme : King Saud University
ID : RSPD2024R940
Organisme : Department of Science and Technology, Ministry of Science and Technology, India
ID : SR/FST/LS-I/2017/05[C]; SR/PURSE Phase 2/39[C])
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Conway ME (2020) Alzheimer’s disease: targeting the glutamatergic system. Biogerontology 21
Tönnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer’s disease. Journal of Alzheimer’s Disease 57
Angelova PR, Abramov AY (2018) Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS Lett 592
Liao Y, Dong Y, Cheng J (2017) The function of the mitochondrial calcium uniporter in neurodegenerative disorders. Int J Mol Sci 18
McKhann GM, Knopman DS, Chertkow H, et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s and Dementia 7. https://doi.org/10.1016/j.jalz.2011.03.005
Januska B (Betty) M (2011) Molecules and medicine. American Journal of Health-System Pharmacy 68:. https://doi.org/10.2146/br110001
Ferreira AM, Marques da Silva P (2017) Defining the place of ezetimibe/atorvastatin in the management of hyperlipidemia. American Journal of Cardiovascular Drugs 17
Zhang C (2018) Hazardous reagent substitution: a pharmaceutical perspective. Green Processing and Synthesis 7:. https://doi.org/10.1515/gps-2018-0079
Erickson RP, Larson-Thomé K, Weberg L, et al (2008) Variation in NPC1, the gene encoding Niemann–Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population. Neurosci Lett 447:. https://doi.org/10.1016/j.neulet.2008.09.046
Kivipelto M, Helkala EL, Laakso MP, et al (2001) Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. Br Med J 322:. https://doi.org/10.1136/bmj.322.7300.1447
Whitmer RA, Sidney S, Selby J, et al (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:. https://doi.org/10.1212/01.WNL.0000149519.47454.F2
Refolo LM, Pappolla MA, Malester B, et al (2000) Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol Dis 7:. https://doi.org/10.1006/nbdi.2000.0304
Vance JE (2012) Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. DMM Disease Models and Mechanisms 5
Olmastroni E, Molari G, De Beni N, et al (2022) Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies. Eur J Prev Cardiol 29
Damirchi M, Aghaie M, Sedighi S, et al (2023) The role of immunosuppression in the development of COVID-19 in systemic lupus erythematosus patients: a brief report. Iran J Med Sci 48:. https://doi.org/10.30476/ijms.2022.94402.2565
Fonseca ACRG, Resende R, Oliveira CR, Pereira CMF (2010) Cholesterol and statins in Alzheimer’s disease: current controversies. Exp Neurol 223
Isingrini E, Desmidt T, Belzung C, Camus V (2009) Endothelial dysfunction: a potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer’s disease? Current Opinion in Investigational Drugs 10
Evans BA, Evans JE, Baker SP, et al (2009) Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer’s disease. Dement Geriatr Cogn Disord 27:. https://doi.org/10.1159/000221835
Grimm A, Friedland K, Eckert A (2016) Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease. Biogerontology 17
Santos RX, Correia SC, Zhu X, et al (2013) Mitochondrial DNA oxidative damage and repair in aging and Alzheimer’s disease. Antioxid Redox Signal 18
Tyumentsev MA, Stefanova NA, Muraleva NA, et al (2018) Mitochondrial dysfunction as a predictor and driver of Alzheimer’s disease-like pathology in OXYS rats. Journal of Alzheimer’s Disease 63:. https://doi.org/10.3233/JAD-180065
Cenini G, Voos W (2019) Mitochondria as potential targets in Alzheimer disease therapy: an update. Front Pharmacol 10
Rossi MJ, Pekkurnaz G (2019) Powerhouse of the mind: mitochondrial plasticity at the synapse. Curr Opin Neurobiol 57
Volmering E, Niehusmann P, Peeva V, et al (2016) Neuropathological signs of inflammation correlate with mitochondrial DNA deletions in mesial temporal lobe epilepsy. Acta Neuropathol 132:. https://doi.org/10.1007/s00401-016-1561-1
Pérez MJ, Ponce DP, Osorio-Fuentealba C, et al (2017) Mitochondrial bioenergetics is altered in fibroblasts from patients with sporadic Alzheimer’s disease. Front Neurosci 11:. https://doi.org/10.3389/fnins.2017.00553
Fišar Z, Hansíková H, Křížová J, et al (2019) Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer’s disease and depressive disorder. Mitochondrion 48:. https://doi.org/10.1016/j.mito.2019.07.013
Lyons A, Murphy KJ, Clarke R, Lynch MA (2011) Atorvastatin prevents age-related and amyloid-β-induced microglial activation by blocking interferon-γ release from natural killer cells in the brain. J Neuroinflammation 8:. https://doi.org/10.1186/1742-2094-8-27
Zhang LL, Sui HJ, Liang B, et al (2014) Atorvastatin prevents amyloid-β peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway. Acta Pharmacol Sin 35:. https://doi.org/10.1038/aps.2013.203
Li X-H, Li X-H, Zhang Y-Y, et al (2013) Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease. Clin Interv Aging https://doi.org/10.2147/cia.s40405
Xiao Y, Ma B, McElheny D, et al (2015) Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer’s disease. Nat Struct Mol Biol 22:. https://doi.org/10.1038/nsmb.2991
Salman M, Akram M, Shahrukh M, et al (2022) Effects of pramipexole on beta-amyloid1–42 memory deficits and evaluation of oxidative stress and mitochondrial function markers in the hippocampus of Wistar rat. Neurotoxicology 92:. https://doi.org/10.1016/j.neuro.2022.07.006
Jahn H (2013) Memory loss in Alzheimer’s disease. Dialogues Clin Neurosci 15:. https://doi.org/10.31887/dcns.2013.15.4/hjahn
Tian H, Ding N, Guo M, et al (2019) Analysis of learning and memory ability in an Alzheimer’s disease mouse model using the Morris water maze. J Visual Exp 2019. https://doi.org/10.3791/60055
Manju Gari, Manisha Varshney (2020) Evaluation of learning and memory in rats through elevated plus maze model. J Biomed Pharmaceut Res 9. https://doi.org/10.32553/jbpr.v9i2.727
Mailloux RJ (2021) An update on methods and approaches for interrogating mitochondrial reactive oxygen species production. Redox Biol 45
Salman M, Tabassum H, Parvez S (2020) Nrf2/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats. DMM Disease Models Mech 13:. https://doi.org/10.1242/dmm.045021
Baracca A, Sgarbi G, Solaini G, Lenaz G (2003) Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F0 during ATP synthesis. Biochim Biophys Acta Bioenerg 1606:. https://doi.org/10.1016/S0005-2728(03)00110-5
Malhotra PA (2019) Impairments of attention in Alzheimer’s disease. Curr Opin Psychol 29
Moujalled D, Strasser A, Liddell JR (2021) Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 28
Salman M, Sharma P, Alam MI, et al (2022) Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington’s disease like symptoms in rats. Nutr Neurosci 25:. https://doi.org/10.1080/1028415X.2021.1913319
Yu C, Xiao JH (2021) The Keap1-Nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev 2021
Martins IVA, Rivers-Auty J, Allan SM, Lawrence CB (2017) Mitochondrial abnormalities and synaptic loss underlie memory deficits seen in mouse models of obesity and Alzheimer’s disease. Journal of Alzheimer’s Disease 55:. https://doi.org/10.3233/JAD-160640
Zafeer MF, Firdaus F, Anis E, Mobarak Hossain M (2019) Prolong treatment with Trans-ferulic acid mitigates bioenergetics loss and restores mitochondrial dynamics in streptozotocin-induced sporadic dementia of Alzheimer’s type. Neurotoxicology 73:. https://doi.org/10.1016/j.neuro.2019.04.006
Smarr BL, Grant AD, Zucker I, et al (2017) Sex differences in variability across timescales in BALB/c mice. Biol Sex Differ 8:. https://doi.org/10.1186/s13293-016-0125-3
Pilipenko V, Narbute K, Amara I, et al (2019) GABA-containing compound gammapyrone protects against brain impairments in Alzheimer’s disease model male rats and prevents mitochondrial dysfunction in cell culture. J Neurosci Res 97:. https://doi.org/10.1002/jnr.24396